J. D. Sipe and A. S. Cohen, Review: History of the Amyloid Fibril, Journal of Structural Biology, vol.130, pp.88-98, 2000.

H. P. Missmahl and M. Hartwig, Polarization studies on the relation between nodular and fibrillary changes in the brain in Alzheimer's disease and nodularlike deposits of amyloid substance in various organs, Deutsche Zeitschrift Fur Nervenheilkunde, vol.171, issue.3, pp.173-80, 1954.

V. Bellotti and F. Chiti, Amyloidogenesis in Its Biological Environment: Challenging a Fundamental Issue in Protein Misfolding Diseases', Current Opinion in Structural Biology, Catalysis and regulation / Proteins, vol.18, pp.771-79, 2008.

M. , Pepys and others, Amyloid P Component. A Critical Review, pp.274-95, 1997.

J. Li and . Others, In Vivo Fragmentation of Heparan Sulfate by Heparanase Overexpression Renders Mice Resistant to Amyloid Protein A Amyloidosis, Proceedings of the National Academy of Sciences of the United States of America, vol.102, pp.6473-77, 2005.

R. A. Kyle, Amyloidosis: A Convoluted Story, British Journal of Haematology, vol.114, issue.3, pp.529-567, 2001.

, Amyloid Persistence in Decellularized Liver: Biochemical and Histopathological Characterization, The International Journal of Experimental and Clinical Investigation: The Official Journal of the International Society of Amyloidosis, vol.23, pp.1-7, 2016.

V. Bellotti, P. Mangione, and G. Merlini, Review: Immunoglobulin Light Chain Amyloidosis-The Archetype of Structural and Pathogenic Variability, Journal of Structural Biology, vol.130, issue.2, pp.280-89, 2000.

L. Obici and . Others, Structure, Function and Amyloidogenic Propensity of Apolipoprotein A-I, Amyloid, vol.13, issue.4, pp.191-205, 2006.

G. Esposito and . Others, Removal of the N-Terminal Hexapeptide from Human ?2-Microglobulin Facilitates Protein Aggregation and Fibril Formation', Protein Science, vol.9, pp.831-876, 2000.

K. Lundmark and . Others, Transmissibility of Systemic Amyloidosis by a Prion-like Mechanism, Proceedings of the National Academy of Sciences of the United States of America, vol.99, pp.6979-84, 2002.

J. Paul, Pathogenetic Mechanisms of Amyloid A Amyloidosis, Proceedings of the National Academy of Sciences of the United States of America, vol.110, pp.16115-16135, 2013.

I. Reserves, Orphanet: Amylose AA, issue.13, 2018.

, Obesity Is a Significant Susceptibility Factor for Idiopathic AA Amyloidosis, Amyloid, vol.25, issue.1, pp.37-45, 2018.


S. Mahmood and G. Palladini, Update on Treatment of Light Chain Amyloidosis, Haematologica, vol.99, pp.209-230, 2014.

, Guideline of Transthyretin-Related Hereditary Amyloidosis for Clinicians, Orphanet Journal of Rare Diseases, vol.8, 2013.

, Molecular Pathogenesis of Human Amyloidosis: Lessons from ?2-Microglobulin-Related Amyloidosis, Pathology International, vol.66, pp.193-201, 2016.

P. Mollee and . Others, How to Diagnose Amyloidosis, Internal Medicine Journal, vol.44, issue.18, pp.7-17, 2014.

L. Karafiatova and T. Pika, Amyloid Cardiomyopathy, Biomedical Papers of the Medical Faculty of the University Palacky, vol.161, issue.2, pp.117-144, 2017.

S. C. Shin, J. Robinson-papp, and &. Neuropathies', The Mount Sinai Journal of Medicine, vol.79, issue.6, pp.733-781, 2012.

, Vitreous Amyloidosis: Ocular, Systemic, and Genetic Insights, Pradeep Venkatesh and others, vol.124, pp.1014-1036, 2017.

M. Samar, Renal Amyloidosis: Origin and Clinicopathologic Correlations of 474 Recent Cases, Clinical Journal of the American Society of Nephrology, vol.8, issue.9, pp.1515-1538, 2013.

L. M. Dember, Amyloidosis-Associated Kidney Disease, Journal of the American Society of Nephrology, vol.17, pp.3458-71, 2006.

A. Khoor and T. V. Colby, Amyloidosis of the Lung, Archives of Pathology & Laboratory Medicine, vol.141, pp.247-54, 2017.

R. Manur and I. Lamzabi, Amyloidosis Diagnosed in Cytology Specimen of Pleural Effusion: A Case Report, Diagnostic Cytopathology, vol.46, pp.522-546, 2018.

, Pleural Amyloidosis Imitating Pleural Malignancy, Respiratory Medicine Case Reports, vol.20, pp.195-97, 2017.

T. George, Localized Amyloidosis of the Head and Neck and Upper Aerodigestive and Lower Respiratory Tracts, Rhinology & Laryngology, vol.93, pp.374-79, 1984.


M. M. Reynolds and . Others, Ocular Manifestations of Familial Transthyretin Amyloidosis, American Journal of Ophthalmology, vol.183, pp.156-62, 2017.

K. Rowe and . Others, Review of the Literature', Cureus, vol.9, 2017.

S. Karoui and . Others, Amyloidosis: Unusual Localization of Gastrointestinal Amyloidosis, Clinical Journal of Gastroenterology, vol.4, pp.198-201, 2011.

J. Perry, S. Pickhardt, and . Bhalla, Unusual Nonneoplastic Peritoneal and Subperitoneal Conditions: CT Findings, RadioGraphics, vol.25, pp.719-749, 2005.

F. S. Buck and M. N. Koss, Hepatic Amyloidosis: Morphologic Differences between Systemic AL and AA Types, Human Pathology, vol.22, pp.904-911, 1991.

P. Skok and . Others, Splenic Rupture in Systemic Amyloidosis -Case Presentation and Review of the Literature, Zeitschrift Fur Gastroenterologie, vol.47, issue.3, pp.292-95, 2009.

P. N. Hawkins, J. P. Lavender, and M. B. Pepys, Evaluation of Systemic Amyloidosis by Scintigraphy with 123I-Labeled Serum Amyloid P Component, The New England Journal of Medicine, vol.323, pp.508-521, 1990.

M. Pauline and G. Grateau, Osteo-Articular Manifestations of Amyloidosis, Best Practice & Research. Clinical Rheumatology, vol.26, pp.459-75, 2012.

P. N. Hawkins and M. B. Pepys, Imaging Amyloidosis with Radiolabelled SAP, European Journal of Nuclear Medicine, vol.22, issue.36, pp.595-99, 1995.

M. Christopher, . Clark, and . Others, Use of Florbetapir-PET for Imaging Beta-Amyloid Pathology, JAMA, vol.305, pp.275-83, 2011.

, Imaging Cardiac Amyloidosis: A Pilot Study Using 18 F-Florbetapir Positron Emission Tomography, European Journal of Nuclear Medicine and Molecular Imaging, vol.41, issue.9, pp.1652-62, 2014.

T. Wagner and . Others, Extracardiac 18F-Florbetapir Imaging in Patients with Systemic Amyloidosis: More than Hearts and Minds, European Journal of Nuclear Medicine and Molecular Imaging, vol.45, pp.1129-1167, 2018.

E. William, Imaging Brain Amyloid in Alzheimer's Disease with Pittsburgh Compound-B', Annals of Neurology, vol.55, issue.3, pp.306-325, 2004.

, Visualization of Multiple Organ Amyloid Involvement in Systemic Amyloidosis Using 11C-PiB PET Imaging, European Journal of Nuclear Medicine and Molecular Imaging, vol.45, issue.3, pp.452-61, 2018.

A. Van, D. Gucht, and . Others, Apical Sparing Pattern of Left Ventricular Myocardial (99m)Tc-HMDP Uptake in Patients with Transthyretin Cardiac Amyloidosis, Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology, 2017.

, , vol.42, p.44

, Pleural Amyloidosis Imitating Pleural Malignancy

, Myocardial Native T2 Measurement to Differentiate Light-Chain and Transthyretin Cardiac Amyloidosis and Assess Prognosis, Journal of Cardiovascular Magnetic Resonance, vol.20, issue.1, 2018.

E. Perugini and . Others, Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99m Tc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy, Journal of the American College of Cardiology, vol.46, pp.1076-84, 2005.

A. Galat and J. Rosso, Usefulness of 99mTc-HMDP Scintigraphy for the Etiologic Diagnosis and Prognosis of Cardiac Amyloidosis, Amyloid, vol.22, pp.210-230, 2015.


, Early Phase (99)Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac Amyloidosis, Arnault Galat and others, vol.10, pp.601-604, 2017.

, Lung Uptake during 99mTc-Hydroxymethylene Diphosphonate Scintigraphy in Patient with TTR Cardiac Amyloidosis: An Underestimated Phenomenon, International Journal of Cardiology, vol.254, pp.346-50, 2018.


, Cardiac Denervation Evidenced by MIBG Occurs Earlier than Amyloid Deposits Detection by Diphosphonate Scintigraphy in TTR Mutation Carriers, European Journal of Nuclear Medicine and Molecular Imaging, vol.45, pp.1108-1126, 2018.

G. Maria, . Trivieri, and . Others, 18F-Sodium Fluoride PET/MR for the Assessment of Cardiac Amyloidosis, Journal of the American College of Cardiology, vol.68, pp.2712-2726, 2016.


T. Iida, H. Yamano, and H. Nakase, Systemic Amyloidosis with Gastrointestinal Involvement: Diagnosis from Endoscopic and Histological Views, Journal of Gastroenterology and Hepatology, 2017.

N. M. , Laryngeal Amyloidosis: Diagnosis, Pathophysiology and Management, The Journal of Laryngology and Otology, vol.131, issue.S2, pp.41-47, 2017.

F. Bontemps and . Others, Pleural Amyloidosis: Thoracoscopic Aspects, European Respiratory Journal, vol.8, issue.6, p.55, 1995.

N. Magy and -. Bertrand, Amyloses Systémiques : Nouveautés Thérapeutiques', Médecine Thérapeutique, vol.15, pp.95-101, 2009.

G. Merlini, D. C. Seldin, and M. A. Gertz, Amyloidosis: Pathogenesis and New Therapeutic Options, Journal of Clinical Oncology, vol.29, pp.1924-1957, 2011.

F. Salvi and . Others, Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis, Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association, vol.27, issue.9, pp.212-226, 2018.


M. S. Maurer and D. R. Grogan, Tafamidis in Transthyretin Amyloid Cardiomyopathy: Effects on Transthyretin Stabilization and Clinical Outcomes, Circulation. Heart Failure, vol.8, issue.3, pp.519-545, 2015.

M. S. Maurer and J. H. Schwartz, Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy, New England Journal of Medicine, 2018.

L. John, Repurposing Diflunisal for Familial Amyloid Polyneuropathy: A Randomized Clinical Trial, JAMA : The Journal of the American Medical Association, vol.310, pp.2658-67, 2013.

R. Sant, Repositioning Tolcapone as a Potent Inhibitor of Transthyretin Amyloidogenesis and Associated Cellular Toxicity, Nature Communications, vol.7, p.10787, 2016.


, Term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR) -Full Text View -ClinicalTrials

, Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis, Journal of Medicinal Chemistry, 2018.

D. Merrill, . Benson, and . Others, Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis, New England Journal of Medicine, vol.379, issue.1, pp.22-31, 2018.

D. Adams, . Others, and . Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis, The New England Journal of Medicine, vol.379, issue.1, pp.11-21, 2018.

M. Stoppini and V. Bellotti, Systemic Amyloidosis: Lessons from ?2-Microglobulin, The Journal of Biological Chemistry, vol.290, pp.9951-58, 2015.

O. Cappelli, Lung Uptake during 99mTc-Hydroxymethylene Diphosphonate Scintigraphy in Patient with TTR Cardiac Amyloidosis

L. Baratto and . Others, 18F-Florbetaben Whole-Body PET/MRI for Evaluation of Systemic Amyloid Deposition', EJNMMI Research, vol.8, 2018.

T. Wagner and . Others, Extracardiac 18F-Florbetapir Imaging in Patients with Systemic Amyloidosis: More than Hearts and Minds, European Journal of Nuclear Medicine and Molecular Imaging, vol.45, pp.1129-1167, 2018.

S. Mahmood and F. Bridoux, Natural History and Outcomes in Localised Immunoglobulin Light-Chain Amyloidosis: A Long-Term Observational Study, The Lancet Haematology, vol.2, pp.241-50, 2015.